Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception
Open Access
- 12 March 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 345 (1) , 47-53
- https://doi.org/10.1016/s0014-2999(97)01584-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1)Life Sciences, 1997
- Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatmentBrain Research, 1995
- Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brainLife Sciences, 1994
- Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1-but not δ2-opioid receptorsLife Sciences, 1994
- The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesiaLife Sciences, 1994
- Agonist and antagonist activities of ligands derived from naltrexone and oxymorphoneLife Sciences, 1992
- κ3 opiate receptor binding in the mouse and ratEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective δ agonist invivoLife Sciences, 1990
- Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadleLife Sciences, 1988
- Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatmentLife Sciences, 1988